Navigation Links
Veridex Completes Acquisition of Immunicon Corporation Assets
Date:8/1/2008

RARITAN, N.J., Aug. 1 /PRNewswire/ -- Veridex, LLC announced today it has completed its previously announced acquisition of substantially all of the assets of Immunicon Corporation (OTC Bulletin Board: IMMC) and its wholly-owned subsidiaries.

The assets acquired include intellectual property, product inventory and clinical data as well as all technologies related to the CellSearch(TM) System, the first diagnostic test to automate the detection and enumeration of circulating tumor cells (CTCs), cancer cells that detach from solid tumors and enter the blood stream. The CellSearch(TM) System is currently cleared for the prognosis and monitoring of patients with metastatic breast, metastatic colorectal and metastatic prostate cancer. As part of the agreement, Veridex also received all technologies related to Repeat-Free(TM) (RF) Poseidon(TM) Fluorescent In-Situ Hybridization (FISH) Probes, which are the latest advance in FISH DNA probes.

"This asset purchase ensures the role of CellSearch(TM) in the future of Veridex," said Ken Berlin, General Manager, Veridex, LLC. "It underscores our continued commitment to the medical community and to cancer patients who may benefit from technologies like the CellSearch(TM) System."

Veridex and Immunicon have partnered since 2000 to develop and commercialize novel cancer diagnostic platforms and products.

About Veridex

Veridex, LLC, a Johnson & Johnson company, is an organization dedicated to providing physicians with high-value in vitro diagnostic oncology products. Veridex's products may significantly benefit patients through earlier disease detection and may enable personalized strategies to help improve patient management and outcomes. For more information, please visit http://www.veridex.com.


'/>"/>
SOURCE Veridex, LLC
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Aurora Health Care Completes System-Wide Conversion to Masimo SET Pulse Oximetry Technology
2. Emisstar Completes 2-Year Emission Control Technology Showcase
3. Clear Catheter Systems Completes $600-Million Financing, Opens Cleveland Office
4. iCAD Completes Acquisition of CAD Sciences
5. Vertos Medical Inc. Completes Series C Financing
6. Houston-Based Tyrell, Inc. Completes $28 Million Private Equity Financing
7. Tianyin Pharmaceutical Co., Inc. Completes Production for Earthquake
8. Two Little Hands Productions Completes the Second Series of Signing Time With Two New DVDs
9. BMP Sunstone Completes Acquisition of Shanghai Rongheng Pharmaceutical Co., Ltd
10. USHIFU, LLC Completes Acquisition of Focus Surgery, Inc.
11. Southern Home Medical Equipment Completes 1-for-1,000 Reverse Split and Begins Trading Under New Symbol SHOM
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... , ... April 25, 2017 , ... There is no ... Hospital, according to a special report in the May issue of Consumer Reports focused ... highest quality ranking for results achieved during and after coronary bypass and aortic valve ...
(Date:4/25/2017)... , ... April 25, 2017 , ... ... solutions, announces the continuation of its strategic partnership with and platinum sponsorship of ... nations in the safe and effective management of complex spine deformity cases, particularly ...
(Date:4/24/2017)... ... April 24, 2017 , ... ... Bring Your Own Device (BYOD) capabilities at Telehealth 2.0, the American Telemedicine Association’s ... bundles, which pairs medical devices with a pre-programmed tablet in a remarkably easy-to-use ...
(Date:4/24/2017)... ... 24, 2017 , ... The Santana Telehealth Project was honored with the 2017 ... American Telemedicine Association’s annual conference, on April 23 in Orlando, FL. , “I am ... the lives of the poor and underserved in other parts of the world,” said ...
(Date:4/24/2017)... TX (PRWEB) , ... April 24, 2017 , ... As ... Memorial Museum today to honor the victims of the Holocaust and Nazi persecution, ... ceremonies at Hadamar and Auschwitz on its CMATH Champions trip to Germany and Poland ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... Eyevensys, a private biotechnology company ... expression technology that enables the safe, local, sustained production ... wide range of ophthalmic diseases, announces it has received ... Agency (MHRA) to advance its technology into clinical development. ... The EyeCET ...
(Date:4/19/2017)... , April 19, 2017 The Mobile X-Ray ... showcase a healthy CAGR during the forecast period ... in the global digital mobile X-Ray devices market, which is ... in 2017, expanding at a CAGR of 7% over the ... $ opportunity of more than US$ 100 Mn in 2017 ...
(Date:4/19/2017)... The Global Effective Microorganisms (EM) Market ... has covered and analysed the potential of Global Effective Microorganisms ... shares and growth factors. The report identifies and analyses the ... the global market. ... 152 Tables and Figures, 6 Major Company Profiles, spread across ...
Breaking Medicine Technology: